scholarly journals Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

2013 ◽  
Vol 108 (10) ◽  
pp. 2039-2044 ◽  
Author(s):  
C Palmieri ◽  
O Gojis ◽  
B Rudraraju ◽  
C Stamp-Vincent ◽  
D Wilson ◽  
...  
Keyword(s):  
Prognostic Factor ◽  
Steroid Receptor ◽  
Platinum Resistance ◽  
Epithelial Cancer ◽  
Poor Prognostic Factor ◽  
Steroid Receptor Coactivator ◽  
Ovarian Epithelial Cancer

scholarly journals p53 overexpression is Not an independent prognostic factor for patients with primary ovarian epithelial cancer

Cancer ◽  
1997 ◽  
Vol 80 (5) ◽  
pp. 892-898 ◽  
Author(s):  
Gamal H. Eltabbakh ◽  
Jerome L. Belinson ◽  
Alexander W. Kennedy ◽  
Charles V. Biscotti ◽  
Graham Casey ◽  
...  
Keyword(s):  
Prognostic Factor ◽  
Independent Prognostic Factor ◽  
Epithelial Cancer ◽  
P53 Overexpression ◽  
Ovarian Epithelial Cancer

scholarly journals Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients

Cells ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1796
Author(s):  
Markus Eckstein ◽  
Verena Lieb ◽  
Rudolf Jung ◽  
Danijel Sikic ◽  
Katrin Weigelt ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Prognostic Factor ◽  
Tumor Cells ◽  
Immune Cells ◽  
Potential Candidate ◽  
Poor Prognostic Factor ◽  
Risk Of Death ◽  
Increased Risk ◽  
Muscle Invasive ◽  
Disease Specific

Urothelial bladder cancer (BCa) is the ninth most commonly diagnosed cancer worldwide and accounts for approximately 3% of global cancer diagnoses. We are interested in prognostic markers that may characterize tumor cells (TCs) and immune cells (ICs) and their relationship in BCa. A potential candidate marker that meets these criteria is progranulin (GP88), which is expressed separately in TCs and ICs. We analyzed GP88 expression by immunohistochemistry (IHC) in 196 muscle-invasive BCa samples using a tissue microarray. The immunoreactive score for GP88 staining in TCs and the percentage of GP88-positive ICs was determined. An easy cutoff for the staining status of TCs (positive vs. negative) and ICs (0% vs. >0%) and, more generally, negative vs. positive GP88 staining could be applied. We detected 93 patients (47.4%) and 92 patients (46.9%) with GP88-positive TCs or ICs, respectively. The IHC results were correlated with clinicopathological and survival data. Positive GP88 staining in TCs appeared to be an independent poor prognostic factor for disease-specific survival (DSS) (RR (relative risk) = 1.74; p = 0.009) and recurrence-free survival (RFS) (RR = 1.92; p = 0.002). In contrast, negative GP88 staining in ICs was an independent negative predictor for overall survival (OS) (RR = 2.18; p < 0.001), DSS (RR = 2.84; p < 0.001) and RFS (RR = 2.91; p < 0.001) in multivariate Cox’s regression analysis. When combining GP88 staining in TCs and ICs, a specific combination of GP88-positive TCs and GP88-negative ICs was associated with a 2.54-fold increased risk of death, a 4.21-fold increased risk of disease-specific death and a 4.81-fold increased risk of recurrence compared to GP88-negative TCs and GP88-positive ICs. In summary, GP88 positivity in TCs is a negative prognostic factor for DSS and RFS. In addition, GP88 positivity can mark ICs that are associated with a good prognosis (OS, DSS and RFS). The combination of GP88 staining in TCs and ICs appears to be a significant independent prognostic biomarker in muscle-invasive BCa.

P-607 Evaluation of two phosphorylation sites establishes Aktactivation as a poor prognostic factor for all stages of NSCLC tumors

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S278
Author(s):  
P. Dennis ◽  
J. Tsurutani ◽  
J. Fukuoka ◽  
H. Tsurutani ◽  
J. Shih ◽  
...  
Keyword(s):  
Prognostic Factor ◽  
Phosphorylation Sites ◽  
Poor Prognostic Factor

Taxol (T): An active new drug in ovarian epithelial cancer (OVCA)

1989 ◽  
Vol 32 (1) ◽  
pp. 111 ◽  
Author(s):  
W.P. McGuire ◽  
E.K. Rowinsky ◽  
N.B. Rosenshein ◽  
F.C. Grumbine ◽  
M.B. Dillon ◽  
...  
Keyword(s):  
Epithelial Cancer ◽  
New Drug ◽  
Ovarian Epithelial Cancer
Sign in / Sign up

Export Citation Format

Share Document